nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
经神经内镜下不同入路手术治疗垂体腺瘤的疗效观察
基金项目(Foundation): 河南省医学科技攻关计划项目(LHGJ20220688)
邮箱(Email):
DOI:
发布时间: 2025-04-21
出版时间: 2025-04-21
网络发布时间: 2025-04-21
移动端阅读
摘要:

目的 基于应激反应、嗅觉功能及视觉功能变化探讨垂体腺瘤患者经神经内镜下不同入路手术治疗的效果。方法 回顾性分析2021年1月至2023年9月在河南科技大学第一附属医院接受治疗的102例垂体腺瘤患者的临床资料,依据治疗方法分为A组(53例)和B组(49例)。A组给予神经内镜下经鼻腔蝶窦入路手术治疗,B组给予神经内镜下经鼻中隔黏膜下蝶窦入路手术治疗。术后随访6个月,对两组手术指标、嗅觉功能、视觉功能、应激反应、基质金属蛋白酶-9(MMP-9)、胰岛素样生长因子-1(IGF-1)、沉默信息调节因子1(SIRT1)、缺氧诱导因子-1α(HIF-1α)和并发症进行比较。结果 与A组比较,B组术中出血量及鼻甲折断/切除占比更低、手术及术后住院的时间均更短(P<0.05),而A组和B组肿瘤全切占比的差异无统计学意义(P>0.05)。术后6个月,两组五味试嗅液测试分值均高于术后3个月(P<0.05);A组术后6个月低于术前(P<0.05);术后3个月,两组五味试嗅液测试分值均低于术前;术后3、6个月,B组高于A组(P<0.05)。与术前比较,术后1个月两组视野模式标准差(PSD)均降低,视野指数(VFI)、视野平均缺损(MD)值均升高(P<0.05),但以上指标A、B两组比较差异无统计学意义(P>0.05)。两组术后1 d的应激指标较术前均升高(P<0.05),B组比A组低。两组术后1 d的血清MMP-9、IGF-1、SIRT1、HIF-1α水平较术前均降低(P<0.05),但A、B两组比较差异无统计学意义(P>0.05)。A组和B组随访期间的并发症发生率比较,差异无统计学意义(P>0.05)。结论 两种手术入路治疗垂体腺瘤均可取得较好的肿瘤切除效果,并调节患者血清MMP-9、IGF-1、SIRT1、HIF-1α水平,对患者视觉功能的影响差别不大,且安全性良好,但经鼻中隔黏膜下蝶窦入路在减少术中出血量、鼻甲折断/切除情况、缩短手术和住院时间及对患者嗅觉功能、应激反应的影响方面较有优势。

Abstract:

Objective To explore the therapeutic effects of different endoscopic approaches for patients with pituitary adenoma based on stress response, changes in olfactory function and visual function. Methods The research subjects were selected from 102 patients with pituitary adenoma who received treatment at the First Affiliated Hospital of Henan University of Science and Technology from January 2021 to September 2023, and their clinical data were retrospectively analyzed. According to treatment methods,102 patients were divided into group A(53 cases) and group B(49 cases). The group A was treated with neuroendoscopic transnasal-sphenoid sinus approach, and the group B was treated with neuroendoscopic transnasal submucous sphenoid sinus approach.The postoperative follow-up time was 6 months. The surgical indexes, including olfactory function, visual function, stress response and matrix metalloproteinase 9(MMP-9), insulin-like growth factor 1(IGF-1), silent information regulator1(SIRT1), hypoxia inducible factor-1(HIF-1α), and complications during follow-up were compared. Results Compared with the group A, the amount of intraoperative blood loss and proportion of turbinate fracture/resection in the group B were lower, the times of surgery and postoperative hospital stay were shorter(P<0. 05), while there was no difference of the proportion of total resection of tumors in group A and group B(P>0. 05). 6 months after surgery. The scores in the five flavor odor test of both groups at 6 months after surgery were higher than 3 months after surgery(P<0. 05), while group A had lowers cores at 6 months after surgery than before surgery(P<0. 05). At 3months after surgery, the scores of the five flavor odor test in both groups were lower than before surgery, and group B at 3 and 6months after surgery was higher than group A(P< 0. 05). Compared with the preoperative results, at 1 month after surgery, the standard deviation of visual field pattern(PSD) were decreased, the visual field index(VFI) and mean visual field defect(MD) were increased in both groups(P<0. 05), but there was no difference between the two groups(P>0. 05). Compared with before surgery,the levels of stress indicators at 1 d after surgery were all increased in two groups, but compared with the group A, those in group B were lower(P<0. 05). Compared with before surgery, the levels of serum MMP-9, IGF-1, SIRT1, and HIF-1 α at 1 d after surgery were decreased in both groups(P<0. 05), but there was no significant difference between the two groups(P>0. 05). There was no difference of the incidence of complications during the follow-up period between the group A and the group B(P>0. 05). Conclusion Both approaches for treating pituitary adenoma could achieve good tumor resection results and regulate the levels of serum MMP-9,IGF-1, SIRT1, and HIF-1 α in patients. The impact on patients′ visual function was not significantly different, and the safety was good. However, the submucosal sphenoid sinus approach through the nasal septum had advantages in reducing intraoperative bleeding,nasal nail breakage/resection, shortening surgery and hospitalization time, and affecting patients′ olfactory function and stress response.

参考文献

[1]秦勇,吴华伟,吴善武,等.经鼻蝶入路显微镜下垂体腺瘤切除术后蝶窦的变化及蝶窦炎发生的相关因素分析[J].肿瘤研究与临床, 2021, 33(1):48-52.

[2]徐佳,王彬彬,王协锋,等.游离鼻粘膜瓣在垂体腺瘤经鼻入路神经内镜手术鞍底重建中的应用[J].中国临床神经外科杂志, 2022, 27(12):1013-1015.

[3]张世彬,陈图南,吴国材,等.神经导航辅助下扩大经鼻蝶入路神经内镜手术切除巨大侵袭性垂体腺瘤1例[J].中国临床神经外科杂志, 2023, 28(3):219-220.

[4]王华,王伟维,王彪.经鼻中隔-蝶窦入路神经内镜手术切除垂体肿瘤[J].中国临床神经外科杂志, 2023, 28(10):652-653.

[5]刘小海,王任直,代从新. 2018年欧洲内分泌协会难治性垂体腺瘤和垂体腺癌诊治指南的临床意义[J].中华医学杂志, 2018, 98(20):1537-1539.

[6] Schlintl C, Schienle A. Reduced olfactory memory performance is associated with executive function deficits in older adults[J].Exp Aging Res, 2023, 49(4):347-359.

[7]郭卉,黄萍,熊莉娜.不同经鼻-蝶窦入路神经内镜切除术治疗垂体瘤的安全性及有效性研究[J].中国医刊, 2021,56(1):56-60.

[8]肖奎,唐协林,周良学,等.神经内镜经单鼻孔蝶窦入路治疗垂体瘤的临床疗效分析[J].中国临床医生杂志, 2021,49(7):831-833.

[9]司建伟,王松鹤,杨俊杰.神经内镜下与显微镜下经鼻蝶入路手术切除垂体腺瘤的疗效及对PRL、GH、ACTH的影响[J].实用癌症杂志, 2024, 39(2):229-232.

[10]刘婷,贾暄东,汤燕彬,等.艾司氯胺酮在一又二分之一鼻孔蝶窦入路垂体瘤神经内镜切除术中的应用效果[J].中国医药导报, 2023, 20(28):123-126.

[11]王宇,刘志远,章佳跃,等.神经内镜经双侧鼻中隔黏膜下入路治疗垂体腺瘤的疗效分析[J].临床神经外科杂志,2022, 19(3):306-311.

[12]闫俊飞,王立忠,梁晓娟,等.神经内镜辅助下经鼻蝶窦手术治疗垂体瘤的效果及对嗅觉功能、神经内分泌激素水平的影响[J].现代肿瘤医学, 2024, 32(4):646-651.

[13] Ben-Shlomo N, Mudry A, Naples J, et al. Hajek and hirsch:otolaryngology pioneers of endonasal transsphenoidal pituitary surgery[J]. Laryngoscope, 2023, 133(4):807-813.

[14]张欠欠,张维天,叶海波.经鼻中隔入路改良蝶窦开放术治疗孤立性蝶窦病变[J].中国耳鼻咽喉头颈外科, 2020, 27(10):580-582, 567.

[15]何阳.神经内镜下经不同入路手术治疗垂体腺瘤的效果及对鼻腔功能的影响[J].中国临床神经外科杂志, 2019, 24(9):540-542, 572.

[16]乔治强.经鼻内窥镜垂体瘤切除术对垂体瘤患者应激因子水平的影响[J].医学临床研究, 2021, 38(3):410-412.

[17] Sun Y, Zhou K, He M, et al. The effects of different fluorescent indicators in observing the changes of the mitochondrial membrane potential during oxidative stress-induced mitochondrial injury of cardiac h9c2 cells[J]. J Fluoresc, 2020, 30(6):1421-1430.

[18]王子涵,雷琢玮,江迁,等.垂体生长激素腺瘤激素分泌与细胞内质网应激的相关性及临床意义研究[J].神经损伤与功能重建, 2023, 18(4):187-192.

[19]李剑,刘志刚,赵军,等.垂体生长激素腺瘤患者血清mi R-212与SIRT1表达及与预后相关性[J].西部医学,2020, 32(9):1328-1332.

[20]陈炼,赵君爽,孙广烨,等.神经导航多模态系统辅助神经内镜在KnospⅢ、Ⅳ级垂体腺瘤手术中的应用[J].临床神经外科杂志, 2019, 16(2):119-122, 128.

[21]周猛,刘彦廷,田春雷,等.垂体腺瘤经鼻蝶入路神经内镜术后早期并发脑脊液鼻漏的影响因素[J].中国临床神经外科杂志, 2023, 28(12):701-704.

基本信息:

中图分类号:R736.4

引用信息:

[1]古选民,杨晋生,贾云玲,等.经神经内镜下不同入路手术治疗垂体腺瘤的疗效观察[J].临床肿瘤学杂志().

基金信息:

河南省医学科技攻关计划项目(LHGJ20220688)

发布时间:

2025-04-21

出版时间:

2025-04-21

网络发布时间:

2025-04-21

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文